Response to Office Action

IDX-DR

IDX TECHNOLOGIES, INC.

Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88065421
LAW OFFICE ASSIGNED LAW OFFICE 101
MARK SECTION
MARK http://uspto.report/TM/88065421/mark.png
LITERAL ELEMENT IDX-DR
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
OWNER SECTION (current)
NAME IDx, LLC
STREET 2300 OAKDALE BLVD
CITY CORALVILLE
STATE Iowa
ZIP/POSTAL CODE 52241
COUNTRY United States
OWNER SECTION (proposed)
NAME IDx Technologies, Inc
STREET 2300 OAKDALE BLVD
CITY CORALVILLE
STATE Iowa
ZIP/POSTAL CODE 52241
COUNTRY United States
EMAIL XXXX
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
LEGAL ENTITY SECTION (current)
TYPE limited liability company
STATE/COUNTRY WHERE LEGALLY ORGANIZED Iowa
LEGAL ENTITY SECTION (proposed)
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES SECTION (009)(no change)
GOODS AND/OR SERVICES SECTION (044)(current)
INTERNATIONAL CLASS 044
DESCRIPTION
Providing automated diagnostic services related to diabetic retinopathy detection from analysis of retinal images
FILING BASIS Section 1(a)
        FIRST USE ANYWHERE DATE At least as early as 05/00/2018
        FIRST USE IN COMMERCE DATE At least as early as 05/00/2018
GOODS AND/OR SERVICES SECTION (044)(proposed)
INTERNATIONAL CLASS 044
TRACKED TEXT DESCRIPTION
Providing automated diagnostic services related to diabetic retinopathy detection from analysis of retinal images; Medical diagnosis of diabetic retinopathy through analysis of retinal images; Medical testing for diagnostic or treatment purposes in the field of ophthalmology through analysis of retinal images
FINAL DESCRIPTION
Medical diagnosis of diabetic retinopathy through analysis of retinal images; Medical testing for diagnostic or treatment purposes in the field of ophthalmology through analysis of retinal images
FILING BASIS Section 1(a)
       FIRST USE ANYWHERE DATE At least as early as 05/00/2018
       FIRST USE IN COMMERCE DATE At least as early as 05/00/2018
ADDITIONAL STATEMENTS SECTION
SIGNIFICANCE OF MARK DR appearing in the mark means or signifies or is a term of art for diabetic retinopathy in the relevant trade or industry or as used in connection with the goods/services/collective membership organization listed in the application. IDX appearing in the mark has no significance nor is it a term of art in the relevant trade or industry or as used in connection with the goods/services/collective membership organization listed in the application, or any geographical significance.
SIGNATURE SECTION
RESPONSE SIGNATURE /MWC/
SIGNATORY'S NAME Matthew Coryell
SIGNATORY'S POSITION Attorney of record, Iowa bar member
SIGNATORY'S PHONE NUMBER 5152882500
DATE SIGNED 05/28/2019
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Tue May 28 15:24:24 EDT 2019
TEAS STAMP USPTO/ROA-XX.XXX.XXX.XX-2
0190528152424962284-88065
421-6201795d0d2c0646116e6
59516b1c667db7d63350be36f
f1a4d254602db698e752-N/A-
N/A-20190528151444679234



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action


To the Commissioner for Trademarks:

Application serial no. 88065421 IDX-DR(Standard Characters, see http://uspto.report/TM/88065421/mark.png) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 044 for Providing automated diagnostic services related to diabetic retinopathy detection from analysis of retinal images
Original Filing Basis:
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 05/00/2018 and first used in commerce at least as early as 05/00/2018 , and is now in use in such commerce.

Proposed:
Tracked Text Description: Providing automated diagnostic services related to diabetic retinopathy detection from analysis of retinal images; Medical diagnosis of diabetic retinopathy through analysis of retinal images; Medical testing for diagnostic or treatment purposes in the field of ophthalmology through analysis of retinal imagesClass 044 for Medical diagnosis of diabetic retinopathy through analysis of retinal images; Medical testing for diagnostic or treatment purposes in the field of ophthalmology through analysis of retinal images
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 05/00/2018 and first used in commerce at least as early as 05/00/2018 , and is now in use in such commerce.
APPLICANT AND/OR ENTITY INFORMATION
Applicant proposes to amend the following:
Current: IDx, LLC, a limited liability company legally organized under the laws of Iowa, having an address of
      2300 OAKDALE BLVD
      CORALVILLE, Iowa 52241
      United States

Proposed: IDx Technologies, Inc, a corporation of Delaware, having an address of
      2300 OAKDALE BLVD
      CORALVILLE, Iowa 52241
      United States
      XXXX (authorized)

ADDITIONAL STATEMENTS
Significance of wording, letter(s), or numeral(s)
DR appearing in the mark means or signifies or is a term of art for diabetic retinopathy in the relevant trade or industry or as used in connection with the goods/services/collective membership organization listed in the application. IDX appearing in the mark has no significance nor is it a term of art in the relevant trade or industry or as used in connection with the goods/services/collective membership organization listed in the application, or any geographical significance.


SIGNATURE(S)
Response Signature
Signature: /MWC/     Date: 05/28/2019
Signatory's Name: Matthew Coryell
Signatory's Position: Attorney of record, Iowa bar member

Signatory's Phone Number: 5152882500

The signatory has confirmed that he/she is an attorney who is a member in good standing of the bar of the highest court of a U.S. state, which includes the District of Columbia, Puerto Rico, and other federal territories and possessions; and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S. attorney or a Canadian attorney/agent not currently associated with his/her company/firm previously represented the owner/holder in this matter: (1) the owner/holder has filed or is concurrently filing a signed revocation of or substitute power of attorney with the USPTO; (2) the USPTO has granted the request of the prior representative to withdraw; (3) the owner/holder has filed a power of attorney appointing him/her in this matter; or (4) the owner's/holder's appointed U.S. attorney or Canadian attorney/agent has filed a power of attorney appointing him/her as an associate attorney in this matter.

        
Serial Number: 88065421
Internet Transmission Date: Tue May 28 15:24:24 EDT 2019
TEAS Stamp: USPTO/ROA-XX.XXX.XXX.XX-2019052815242496
2284-88065421-6201795d0d2c0646116e659516
b1c667db7d63350be36ff1a4d254602db698e752
-N/A-N/A-20190528151444679234



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed